NIH-funded research R01 grant

Genetics of drug-resistant epilepsy with focal cortical dysplasia

Official title: Clinical genetics of drug-resistant epilepsy with focal cortical dysplasia

Funded at University of Texas Hlth Sci Ctr Houston · NIH-11042860 · Data updated 2026-11-12

Researchers will study the genetic factors behind drug-resistant epilepsy caused by focal cortical dysplasia to uncover what goes wrong in the brain.

More Epilepsy research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Texas Hlth Sci Ctr Houston
NIH-funded
Lab location1 site (Houston, United States)
Project startApril 15, 2021
Project endDecember 31, 2026
Funding year2026
Award (this year)$748,471
NIH project number5R01NS117544-05
Project IDNIH-11042860 on NIH RePORTER

Who could benefit from this research

Could help

Adults and children with focal cortical dysplasia-associated epilepsy who have not achieved seizure control with medications and are undergoing clinical evaluation or surgery.

Less likely to help

Patients without FCD or those not considering surgery or extensive genetic testing may not directly benefit.

What this research studies

This project looks at why some people with epilepsy do not respond to medications, focusing on a brain malformation called focal cortical dysplasia. It will analyze DNA from affected brain tissue and other samples, compare with controls, and explore copy number changes and RNA patterns. The goal is to identify genetic clues that explain why these seizures occur and to lay groundwork for targeted therapies. The study leverages a large, well-characterized patient group and deep clinical data to reveal somatic genetic alterations tied to FCD.

Why it matters

Potential benefit: Finding genetic drivers of FCD could lead to better diagnostic tests and pave the way for personalized treatments for drug-resistant epilepsy.

How similar studies have gone: Previous studies identified a subset of genetic causes, but most FCD cases lack clear genetic explanations; this project expands to a much larger cohort and deeper analyses.

Where this research is happening

  • University of Texas Hlth Sci Ctr Houston
    Houston, United States
    Active

Researchers

  • Principal investigator: Leu, Costin — University of Texas Hlth Sci Ctr Houston
  • Study coordinator: Leu, Costin

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.